1. Cystic fibrosis;Boat, T.F.; Welsh, M.J.; Beaudet, A.L.,1989
2. Recombinant human DNase I reduces the viscosity of;Shak, S.; Capon, D.J.; Hellmiss, R.; Marsters, S.A.; Baker, C.L.,1990
3. Recombinant human DNase inhalation in normal subjects and patients with cystic fibrosis: a phase 1 study;Aitken, M.L.; Burke, W.; McDonald, G.; Shak, S.; Montgomery, A.B.; Smith, A.;JAMA,1992
4. A preliminary study of aerosolized recombinant human deoxyribonuclease I in the treatment of cystic fibrosis;Hubbard, R.C.; McElvaney, N.G.; Birrer, P.; Shak, S.; Robinson, W.W.; Jolley, C.;N Engl J Med,1992
5. Efficacy and safety of short-term administration of aerosolized recombinant human deoxyribonuclease in patients with cystic fibrosis;Ramsey, B.W.; Astley, S.J.; Aitken, M.L.; Burke, W.; Colin, A.A.; Dorkin, H.L.;Am Rev Respir Dis,1993